We look for passionate people to work with us.
Current job openings at MiraKind are listed below.
We are not currently hiring at this time.
If you'd like to know when we're hiring in the future, please send an email to firstname.lastname@example.org.
MiraKind is a non-profit healthcare organization dedicated to educating individuals about the KRAS-variant to prevent disease by expanding access to, and fostering greater awareness and understanding of, this unique class of genetic biomarkers. Specifically, MiraKind is focused on:
- Educating women age 40+ about how genetics, and the KRAS-variant specifically, play a part in cancer prevention.
- Providing the necessary community and information so women feel confident getting tested for the KRAS-variant and taking individually appropriate actions based on results.
- Changing the dialogue, through outreach and scientific advancement, from treating cancer to preventing cancer.
- Building a large, active community for those who have the KRAS-variant, and which can contribute to improving women’s health.
- Becoming a recognized and respected source of information, support, and advocacy for women’s health, specifically as it pertains to cancer.
- Being a trusted source for information and research on estrogen management and women’s cancer prevention.
- Participate/lead clinical research that leads to advances in the understanding of KRAS-variant.
- Conducting research that builds upon the knowledge base of genetics as it relates to women’s cancer.
About MiraKind Founder Joanne Weidhaas, MD, PhD
Joanne is co-founder of MiraDx, founder of MiraKind, and Professor at the David Geffen School of Medicine at UCLA and head of translation research, in the Department of Radiation Oncology. Her pioneering research led to the co-discovery of the KRAS-variant, a strong predictor of cancer risk, tumor biology and treatment response. Her passion to empower individuals with meaningful information to help them take charge of their health led her to found MiraKind and MiraDx. Joanne completed her oncology training at Memorial Sloan-Kettering Cancer Center in New York City and previously served as the Chief of the Breast Cancer Radiation Service at Yale Cancer Center and the Radiation Section Chief of Breast Cancer at the Yale Cancer Center. While on sabbatical at Yale she completed an MBM at Stanford University. She moved to UCLA as Professor and Division Head, Translational Research in 2014. Her dual role as a clinician and researcher has enabled her to apply genetic breakthroughs to the benefit of her patients.